5C1A Stock Overview
Esperite N.V., together with its subsidiaries, operates as a regenerative and predictive medicine company in the Netherlands, Spain, Italy, Switzerland, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Esperite N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.0002 |
| 52 Week High | €0.031 |
| 52 Week Low | €0.0002 |
| Beta | 0 |
| 1 Month Change | -75.00% |
| 3 Month Change | -98.18% |
| 1 Year Change | -98.80% |
| 3 Year Change | -99.52% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5C1A | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.3% | 1.6% |
| 1Y | -98.8% | 35.8% | 6.4% |
Return vs Industry: 5C1A underperformed the German Biotechs industry which returned -23.1% over the past year.
Return vs Market: 5C1A underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 5C1A volatility | |
|---|---|
| 5C1A Average Weekly Movement | 3,169.8% |
| Biotechs Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5C1A's share price has been volatile over the past 3 months.
Volatility Over Time: 5C1A's weekly volatility has increased from 1509% to 3170% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Frédéric Amar | https://www.esperite.com |
Esperite N.V., together with its subsidiaries, operates as a regenerative and predictive medicine company in the Netherlands, Spain, Italy, Switzerland, and internationally. It operates through four segments: Stem Cell, The Cell Factory, Genoma, and Other. The company collects, processes, and stores human adult stem cells from the umbilical cord blood and the umbilical cord.
Esperite N.V. Fundamentals Summary
| 5C1A fundamental statistics | |
|---|---|
| Market cap | €481.41k |
| Earnings (TTM) | -€18.72m |
| Revenue (TTM) | €13.57m |
0.0x
P/S Ratio0.0x
P/E RatioIs 5C1A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5C1A income statement (TTM) | |
|---|---|
| Revenue | €13.57m |
| Cost of Revenue | €4.50m |
| Gross Profit | €9.07m |
| Other Expenses | €27.78m |
| Earnings | -€18.72m |
Last Reported Earnings
Jun 30, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 5C1A perform over the long term?
See historical performance and comparison